Chemotherapy for Staphylococcus aureus; combined use of novobiocin and erythromycin and other methods in the treatment of burns.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D002056:Burns / Q000150:complications*; D003879:Dermatologic Agents; D004917:Erythromycin / Q000627:therapeutic use*; D008837:Micrococcus / Q000472:pathogenicity* / Q000628:therapy*; D009675:Novobiocin; D013203:Staphylococcal Infections; D013211:Staphylococcus aureus
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D009675:Novobiocin; D004917:Erythromycin
ANTIBIOTICS/therapeutic use; BURNS/complications; ERYTHROMYCIN/therapeutic use; MICROCOCCAL INFECTIONS/therapy